Threshold Analyte Calibration for LC-MS Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional immunoassay methods for analyte screening in biological specimens lack selectivity and definitiveness, leading to false positives and requiring multiple assays for each analyte class, and are limited by the availability of isotopic standards for newly emerging analytes.
Innovation Solution
The use of Threshold Analyte Calibration (TAC) methods in liquid chromatography-mass spectrometry technology, which involves analyzing biological specimens with and without a reference analyte to calculate a TAC ratio for selective and accurate detection and quantitation of analytes, allowing for multi-analyte detection in a single run without the need for isotopic standards.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If immunoassay methods are used for analyte screening, then high throughput screening is achieved, but selectivity and definitiveness are lost leading to false positives
Solution Approach 1:
The patent segments the screening process into two distinct stages: (1) high-throughput immunoassay screening for initial detection, and (2) targeted mass spectrometry confirmation for definitive identification. This segmentation allows each method to operate in its optimal performance regime, with immunoassay providing rapid initial screening and mass spectrometry providing selective confirmation, thereby resolving the contradiction between throughput and accuracy.
Solution Approach 2:
The patent introduces a decision-tree algorithm as an intermediary that processes immunoassay results and determines which samples require confirmatory mass spectrometry analysis. This intermediary intelligently routes samples based on risk assessment, optimizing the allocation of resources between high-throughput screening and selective confirmation, thus maintaining both productivity and measurement precision.
2Adaptability or versatility
If multiple immunoassays are performed for each analyte class, then comprehensive screening is achieved, but time and resource consumption increase
Solution Approach 1:
The patent employs a single mass spectrometry platform that can universally detect and identify multiple different analytes across various drug classes through selective ion monitoring. This multi-functional capability replaces the need for multiple class-specific immunoassays, allowing comprehensive analyte coverage in a single confirmatory analysis, thereby reducing time loss while maintaining versatility.
Solution Approach 2:
The patent applies partial confirmation strategy where not all immunoassay-positive samples undergo mass spectrometry confirmation. Instead, a decision-tree algorithm identifies high-risk samples that require confirmation, performing confirmation only where necessary. This partial action approach reduces overall screening time while maintaining comprehensive analyte coverage for confirmed positives.
3Measurement precision
If isotopic standards are used for each analyte, then accurate quantification is achieved, but availability is limited for newly emerging analytes
Solution Approach 1:
The patent uses synthetic analogs and structural analogs as surrogate standards that replicate the ionization and fragmentation behavior of target analytes in mass spectrometry. These surrogate standards can be readily synthesized for newly emerging analytes without requiring expensive isotopically labeled compounds, thereby maintaining quantification accuracy while improving adaptability to new substances.
Solution Approach 2:
The patent employs stable isotope dilution only when isotopic standards are available, but alternatively uses isotope-ratio mass spectrometry with natural abundance isotopes or synthetic internal standards. By changing the quantification parameter from requiring isotopic standards to using alternative mass spectral ratios, the method maintains measurement precision while significantly improving adaptability to newly emerging analytes for which isotopic standards are unavailable.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
TAC methods provide definitive, qualitative, and quantitative analyte detection with threshold accuracy, enabling rapid adaptation to newly emerging analytes and reducing the need for multiple assays, while compensating for matrix effects through the use of a spiked reference analyte.
Implementation Method 1
liquid chromatography-mass spectrometry technology
Implementation Method 2
liquid chromatography-mass spectrometry technology
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Provided herein are definitive screening techniques for qualitatively and quantitatively detecting analytes in biological specimens.